Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

USANA Health Sciences Cash on Hand 2010-2025 | USNA

USANA Health Sciences cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  
USANA Health Sciences Annual Cash on Hand
(Millions of US $)
2024 $182
2023 $330
2022 $288
2021 $240
2020 $312
2019 $235
2018 $278
2017 $247
2016 $176
2015 $143
2014 $111
2013 $146
2012 $71
2011 $50
2010 $24
2009 $14
USANA Health Sciences Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $180
2024-12-31 $182
2024-09-30 $365
2024-06-30 $332
2024-03-31 $328
2023-12-31 $330
2023-09-30 $307
2023-06-30 $300
2023-03-31 $295
2022-12-31 $288
2022-09-30 $247
2022-06-30 $230
2022-03-31 $238
2021-12-31 $240
2021-09-30 $249
2021-06-30 $265
2021-03-31 $257
2020-12-31 $312
2020-09-30 $278
2020-06-30 $227
2020-03-31 $194
2019-12-31 $235
2019-09-30 $183
2019-06-30 $234
2019-03-31 $252
2018-12-31 $278
2018-09-30 $321
2018-06-30 $299
2018-03-31 $266
2017-12-31 $247
2017-09-30 $192
2017-06-30 $229
2017-03-31 $176
2016-12-31 $176
2016-09-30 $135
2016-06-30 $112
2016-03-31 $151
2015-12-31 $143
2015-09-30 $174
2015-06-30 $151
2015-03-31 $129
2014-12-31 $111
2014-09-30 $88
2014-06-30 $122
2014-03-31 $147
2013-12-31 $146
2013-09-30 $115
2013-06-30 $96
2013-03-31 $71
2012-12-31 $71
2012-09-30 $77
2012-06-30 $66
2012-03-31 $71
2011-12-31 $50
2011-09-30 $36
2011-06-30 $25
2011-03-31 $33
2010-12-31 $24
2010-09-30 $23
2010-06-30 $28
2010-03-31 $22
2009-12-31 $14
2009-09-30 $13
2009-06-30 $11
2009-03-31 $10
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.567B $0.855B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.342B 30.89
Zoetis (ZTS) United States $69.034B 25.76
Takeda Pharmaceutical (TAK) Japan $47.411B 9.43
Daiichi Sankyo, - (DSNKY) Japan $44.972B 23.05
BeOne Medicines - (ONC) Cayman Islands $27.694B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.360B 0.00
Merck (MKKGY) Germany $16.226B 11.89
Summit Therapeutics (SMMT) United States $14.972B 0.00
Shionogi (SGIOY) Japan $14.581B 14.61
United Therapeutics (UTHR) United States $13.159B 11.64
Neurocrine Biosciences (NBIX) United States $12.599B 43.16
Orion OYJ (ORINY) Finland $10.006B 27.06
IPSEN (IPSEY) France $9.836B 0.00
Corcept Therapeutics (CORT) United States $7.555B 61.41
Stevanato Group S.p.A (STVN) Italy $7.193B 43.98
Madrigal Pharmaceuticals (MDGL) United States $6.277B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.982B 0.00
Ionis Pharmaceuticals (IONS) United States $5.890B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.000B 0.00
Hypermarcas (HYPMY) Brazil $3.132B 20.60
Crinetics Pharmaceuticals (CRNX) United States $2.856B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.782B 9.75
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.489B 13.46
BioCryst Pharmaceuticals (BCRX) United States $2.084B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.077B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.043B 0.00
Indivior (INDV) United States $1.917B 8.13
Centessa Pharmaceuticals (CNTA) United Kingdom $1.693B 0.00
Endo (NDOI) United States $1.618B 0.00
ARS Pharmaceuticals (SPRY) United States $1.563B 0.00
Evotec AG (EVO) Germany $1.410B 0.00
Ocular Therapeutix (OCUL) United States $1.327B 0.00
Guardian Pharmacy Services (GRDN) United States $1.245B 0.00
Dyne Therapeutics (DYN) United States $1.225B 0.00
Harrow (HROW) United States $1.156B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.070B 21.41
Enliven Therapeutics (ELVN) United States $1.058B 0.00
Verve Therapeutics (VERV) United States $0.991B 0.00
Collegium Pharmaceutical (COLL) United States $0.951B 5.13
Akebia Therapeutics (AKBA) United States $0.935B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.902B 0.00
Ardelyx (ARDX) United States $0.864B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.716B 0.00
Elite Pharmaceuticals (ELTP) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.612B 0.00
Xencor (XNCR) United States $0.595B 0.00
Relay Therapeutics (RLAY) United States $0.576B 0.00
Regulus Therapeutics (RGLS) United States $0.568B 0.00
Altimmune (ALT) United States $0.550B 0.00
Theravance Biopharma (TBPH) United States $0.531B 0.00
Bioventus (BVS) United States $0.528B 13.40
AleAnna (ANNA) United States $0.520B 0.00
Zevra Therapeutics (ZVRA) United States $0.496B 0.00
Siga Technologies (SIGA) United States $0.459B 9.58
Amylyx Pharmaceuticals (AMLX) United States $0.455B 0.00
Oruka Therapeutics (ORKA) United States $0.449B 0.00
Tourmaline Bio (TRML) United States $0.432B 0.00
Organogenesis (ORGO) United States $0.415B 0.00
Savara (SVRA) United States $0.358B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.346B 9.35
Aquestive Therapeutics (AQST) United States $0.338B 0.00
Liminatus Pharma (LIMN) United States $0.333B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.83
Tonix Pharmaceuticals Holding (TNXP) United States $0.253B 0.00
Esperion Therapeutics (ESPR) United States $0.218B 0.00
MediWound (MDWD) Israel $0.210B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
ProKidney (PROK) United States $0.204B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
Nanobiotix S.A (NBTX) France $0.202B 0.00
OmniAb (OABI) United States $0.202B 0.00
Aldeyra Therapeutics (ALDX) United States $0.190B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Larimar Therapeutics (LRMR) United States $0.175B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.155B 0.00
Aclaris Therapeutics (ACRS) United States $0.154B 0.00
Journey Medical (DERM) United States $0.148B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.141B 0.00
VAXART, INC (VXRT) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.139B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Champions Oncology (CSBR) United States $0.116B 19.09
Protara Therapeutics (TARA) United States $0.115B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.109B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
Nektar Therapeutics (NKTR) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
Dominari Holdings (DOMH) United States $0.092B 0.00
Wellgistics Health (WGRX) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Surrozen (SRZN) United States $0.085B 0.00
Unicycive Therapeutics (UNCY) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.080B 59.56
ESSA Pharma (EPIX) Canada $0.075B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
FibroGen (FGEN) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Ernexa Therapeutics (ERNA) United States $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.21
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00